Drug Type Monoclonal antibody |
Synonyms IL-13 MAb-CSL, TAL, CSL 362AML + [6] |
Target |
Mechanism CD123 inhibitors(Interleukin-3 receptor subunit alpha inhibitors), Natural killer cells stimulants(Natural killer cells stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Phase 3 | US | 04 Aug 2015 | |
Acute Myeloid Leukemia | Phase 3 | CN | 04 Aug 2015 | |
Acute Myeloid Leukemia | Phase 3 | AU | 04 Aug 2015 | |
Acute Myeloid Leukemia | Phase 3 | BE | 04 Aug 2015 | |
Acute Myeloid Leukemia | Phase 3 | FR | 04 Aug 2015 | |
Acute Myeloid Leukemia | Phase 3 | DE | 04 Aug 2015 | |
Acute Myeloid Leukemia | Phase 3 | IL | 04 Aug 2015 | |
Acute Myeloid Leukemia | Phase 3 | PL | 04 Aug 2015 | |
Acute Myeloid Leukemia | Phase 3 | KR | 04 Aug 2015 | |
Acute Myeloid Leukemia | Phase 3 | TW | 04 Aug 2015 |
Phase 2 | 34 | (Talacotuzumab) | xqpaasfddz(cwoddfygwz) = bjkzqwgkcg owzwqavhlr (wtkwnabber, vmsnckewsh - ukchegxucy) View more | - | 13 Mar 2020 | ||
(Daratumumab) | xqpaasfddz(cwoddfygwz) = mavzdhudhp owzwqavhlr (wtkwnabber, icewvfwwpq - qxmggntqnc) View more | ||||||
Phase 2/3 | 326 | Decitabine (Part B: Decitabine (Alone)) | yylhrjwdwj(mcigjrymxg) = vrcbylfcae aixwnmsmwo (msudnapbam, trnshyazwa - osdppocvdj) View more | - | 28 Feb 2019 | ||
Decitabine+JNJ-56022473 (Part B: Decitabine + JNJ-56022473) | yylhrjwdwj(mcigjrymxg) = jfronjmych aixwnmsmwo (msudnapbam, nmomqpzrsd - rjqypjtbfh) View more |